A Pharmaceutical Frenzy - Knowledge Leaders Capital

A Pharmaceutical Frenzy

April 22, 2014

By Knowledge Leaders Team in Uncategorized

Over the last few months, the MSCI World Health Care sector has struggled to maintain its position at the top of the leaderboard:

As companies swap cancer drugs for flu vaccines, or endeavor into the realm of animal health, we are reminded of just how impactful these investments in R&D (and other intangibles) can be when looking at the overall health of an industry over time. Biotech companies spend more than 30% of sales on research and development efforts, while their Pharmaceutical cousins spend nearly 15%:

Compare these R&D investments as a percent of sales to a Health Care sector average of ~10% and the MSCI World average of 2.4% and it highlights just how much importance companies like Novartis, Glaxo, and Lilly place on the value of intangibles.

These investments can be linked to attributes such as higher than average margins and strong cash flow positions– all achieved with very low leverage:

And, while the Health Care sector as a whole may have reached higher than desirable valuations, a group like Pharmaceuticals appears to be more moderately valued at this point:

Print Friendly, PDF & Email

Tags > MSCI World, pharmaceuticals

Archives

Disclosures

The information presented here is for informational purposes only and is not to be construed as an offer to sell, or the solicitation of an offer to buy, securities. Some investments are not suitable for all investors, and there can be no assurance that any investment strategy will be successful. Hyperlinks may be included in this message that provide direct access to other internet resources, including web sites. While we believe these links are to reliable sources, Knowledge Leaders Capital (“KLC”) has no control over the accuracy or content of information contained on these sites. Although we make every effort to ensure such links are accurate, up to date and relevant, we have no control over pages maintained by external providers. The views expressed by these external providers on their own web pages or on external sites they link to are not necessarily those of Knowledge Leaders Capital.

The information provided on this blog is for illustrative or example purposes only and should not be construed as KLC’s opinion or investment outlook. As of the most recent quarter end, the named companies may have been held by KLC. For full information including additional policies and full disclosures, please visit our website: KnowledgeLeadersCapital.com.

Any reference to Index performance does not represent the performance of any investment product offered by Knowledge Leaders Capital, LLC. An investor cannot invest directly in an index. The performance of client account may vary from the Index performance. Index returns shown are not reflective of actual investor performance nor do they reflect fees and expenses applicable to investing.

Companies are selected for “Spotlights” based on high levels of innovation activities in their respective industries and illustrate innovation being employed across all sectors and geographies. Spotlight selection is separate from stock selection by the investment team. Spotlights are not necessarily representative of investment opportunities and can be selected regardless of investment performance or inclusion as a KLC holding.